http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101287126-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-25 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101287126-B1 |
| titleOfInvention | Pharmaceutical composition for the prevention and treatment of vaginitis and urinary tract infection containing phyto lactic acid bacteria fermentation |
| abstract | The present invention relates to a pharmaceutical composition for preventing and treating vaginitis and urinary tract infection containing phyto lactic acid bacteria fermentation liquid, and more specifically, a mixed fermentation broth of Lactobacillus plantarium DSR CK10 and Lactobacillus plantarium DSR M2 as an active ingredient. The present invention relates to a pharmaceutical composition for preventing and treating vaginitis and urinary tract infection, wherein the pharmaceutical composition of the present invention does not affect lactic acid bacteria having an antibacterial effect in the vagina, and optionally, Escherichia coli (C. E. coli, Enterobacter cloacae, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhimurium, Gardnerella vazinalus vaginalis) and Candida albicans have excellent activity to inhibit urinary tract infection and It can be usefully used as a preventive and therapeutic agent for vaginitis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102337950-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019098752-A1 |
| priorityDate | 2011-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.